4
Changes in Ownership
Lexeo Therapeutics, Inc. Filed Acc 0001209191-23-054913
10% owner bought 454,545 shares at $11.00 ($4,999,995)
- 10% owner acquired 1,703,078 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
Omega Fund VI, L.P. · 10% owner
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-11-07 | Conversion : show line 1 in the form | +1,415,865 | 1,415,865 | D | ||
| 2023-11-07 | Conversion : show line 2 in the form | +287,213 | 1,703,078 | D | ||
| 2023-11-07 | Purchase : show line 3 in the form | +454,545 | $11.00 | $4,999,995 | 2,157,623 | D |
| Open-market purchases · 454,545 sh · avg $11.00 · $4,999,995 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-11-07 | Conversion : show line 4 in the form Series A convertible preferred stock | −14,999,999 | 0 | D |
| 2023-11-07 | Conversion : show line 5 in the form Series B convertible preferred stock | −2,615,533 | 0 | D |
Loading xslF345X05/doc4.xml…